Drug Search Results
More Filters [+]

Amoxicillin

Alternative Names: amoxicillin, amoxycillin, amoxicilline, clamoxyl, amolin, amoxil, amoxi, moxatag, AMOXICILINA, amoxicillinum, amoksicillintrihydrat, polymox, trimox, wymox, utimox, larotid, dispermox, prevpac (copackaged), voquezna triple pak, augmentin '125', voquezna dual pak, augmentin '250', augmentin '400', augmentin xr, augmentin es-600, augmentin '200', augmentin '875', augmentin '500', omeclamox-pak, amoxiclav
Latest Update: 2024-11-21
Latest Update Note: Clinical Trial Update

Product Description

Amoxicillin is used to treat certain infections caused by bacteria, such as pneumonia; bronchitis (infection of the airway tubes leading to the lungs); and infections of the ears, nose, throat, urinary tract, and skin. It is also used in combination with other medications to eliminate H. pylori, a bacteria that causes ulcers. Amoxicillin is in a class of medications called penicillin-like antibiotics. It works by stopping the growth of bacteria. (Sourced from: https://medlineplus.gov/druginfo/meds/a685001.html)

Mechanisms of Action: Cell Wall Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Skin Ulcer | Duodenal Ulcer | Helicobacter Infections | Respiratory Tract Infections | Urinary Tract Infections | Pharyngitis | Tonsillitis | Helicobacter Infections

Known Adverse Events: Diarrhea | Headache | Hypertension | Abdominal Pain | Dysgeusia | Pain Unspecified | Nasopharyngitis | Pharyngitis | Candidiasis | Candidiasis, Vulvovaginal

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Amoxicillin

Countries in Clinic: Australia, Belgium, Benin, Canada, China, Colombia, Croatia, France, Germany, Hungary, India, Ireland, Japan, Kenya, Nepal, Netherlands, New Zealand, Pakistan, Portugal, Romania, Saudi Arabia, Spain, United Kingdom, United States

Active Clinical Trial Count: 17

Highest Development Phases

Phase 3: Acute Respiratory Distress Syndrome|COVID-19|Clostridium Infections|Diarrhea|Febrile Neutropenia|Fractures, Open|Helicobacter Infections|Influenza, Human|Intestinal Diseases|Pneumonia|Respiratory Tract Infections|Urinary Tract Infections|Vaginosis, Bacterial

Phase 2: Buruli Ulcer|Diverticulitis|Pyelonephritis

Phase 1: Communicable Diseases|Duodenal Diseases|Duodenal Ulcer|Esophagitis|Short Bowel Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DURATIOM

P3

Unknown Status

Fractures, Open

2027-12-31

BLMs4BU

P2

Recruiting

Buruli Ulcer

2026-05-31

REMAP-CAP

P3

Recruiting

Pneumonia|COVID-19|Influenza, Human

2026-02-01

DIREBIOT

P2

Unknown Status

Diverticulitis

2025-12-31

Recent News Events